DexCom, Inc.

DXCM

$86.62

Name : DexCom, Inc.

Sector : Healthcare

Industry: Medical Devices

Mark. Cap: $32,686,991,360.00

EPSttm : 2.53

DexCom, Inc.

$86.62

0.97%

$0.85

DXCM — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

4.65

Margin Of Safety %

-6

Put/Call OI Ratio

0.89

EPS Next Q Diff

0.03

EPS Last/This Y

0.52

EPS This/Next Y

0.46

Price

86.61

Target Price

95.12

Analyst Recom

1.42

Performance Q

23.5

Upside

2.2%

Beta

1.48

Ticker: DXCM

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-08-28	DXCM	90.82	1.01	0.38	91395
2026-08-31	DXCM	91.04	1.00	0.14	87245
2026-09-02	DXCM	89.61	0.95	0.44	90841
2026-09-03	DXCM	89.7	0.94	0.09	91445
2026-09-04	DXCM	87.89	0.91	0.49	93337
2026-09-08	DXCM	84.19	0.93	0.67	91153
2026-09-09	DXCM	83.91	0.94	1.09	93164
2026-09-10	DXCM	84.51	0.95	1.80	94375
2026-09-11	DXCM	83.04	0.95	0.29	94818
2026-09-14	DXCM	84.69	1.00	0.58	91528
2026-09-15	DXCM	86.44	0.99	0.25	92404
2026-09-16	DXCM	87.34	0.97	0.42	93567
2026-09-17	DXCM	87.91	0.96	0.19	95294
2026-09-18	DXCM	89.41	0.94	0.33	96554
2026-09-21	DXCM	89.17	0.89	0.27	77633
2026-09-22	DXCM	89.41	0.88	0.72	78938
2026-09-23	DXCM	87.78	0.88	0.55	79236
2026-09-24	DXCM	87.52	0.87	3.09	79760
2026-09-25	DXCM	86.5	0.89	0.76	80969
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-08-28	DXCM	90.64	10.0	-208.6	2.66
2026-08-31	DXCM	91.05	10.0	-222.3	2.66
2026-09-01	DXCM	90.14	10.0	-236.0	2.66
2026-09-02	DXCM	89.69	10.0	-91.1	2.66
2026-09-03	DXCM	89.69	10.0	-86.6	2.66
2026-09-04	DXCM	87.89	10.0	-110.0	2.66
2026-09-08	DXCM	84.49	10.0	-132.7	2.66
2026-09-09	DXCM	83.86	10.0	-93.9	2.66
2026-09-10	DXCM	84.52	10.0	-75.6	2.66
2026-09-11	DXCM	83.07	10.0	-106.1	2.66
2026-09-14	DXCM	84.69	10.0	-60.4	2.66
2026-09-15	DXCM	86.43	10.0	-59.6	2.66
2026-09-16	DXCM	86.43	10.0	-59.6	2.66
2026-09-17	DXCM	87.89	10.0	-77.3	2.66
2026-09-18	DXCM	89.35	10.0	-65.1	2.66
2026-09-21	DXCM	89.15	10.0	-87.7	2.66
2026-09-22	DXCM	89.53	10.0	-80.0	2.66
2026-09-23	DXCM	87.72	10.0	-109.8	2.66
2026-09-24	DXCM	87.46	10.0	-88.8	2.66
2026-09-25	DXCM	86.61	10.0	-97.1	2.66
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-08-28	DXCM	-1.98	2.70	4.46
2026-08-31	DXCM	-2.01	0.83	4.46
2026-09-01	DXCM	-2.04	0.83	4.46
2026-09-02	DXCM	-2.04	0.83	4.46
2026-09-03	DXCM	-2.04	0.83	4.46
2026-09-04	DXCM	-2.04	0.83	4.46
2026-09-08	DXCM	-2.04	1.16	4.46
2026-09-09	DXCM	-2.04	1.16	4.46
2026-09-10	DXCM	-2.04	1.16	4.46
2026-09-11	DXCM	-2.04	1.16	4.76
2026-09-14	DXCM	-2.09	1.16	4.76
2026-09-15	DXCM	-2.09	1.16	4.75
2026-09-16	DXCM	-2.24	1.16	4.75
2026-09-17	DXCM	-2.39	1.16	4.75
2026-09-18	DXCM	-2.39	1.16	4.75
2026-09-21	DXCM	-2.36	1.19	4.75
2026-09-23	DXCM	-2.37	1.19	4.75
2026-09-24	DXCM	-2.37	1.19	4.75
2026-09-25	DXCM	-2.37	1.19	4.65
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

0.7

Avg. EPS Est. Current Quarter

0.67

Avg. EPS Est. Next Quarter

0.73

Insider Transactions

-2.37

Institutional Transactions

1.19

Beta

1.48

Average Sales Estimate Current Quarter

1328

Average Sales Estimate Next Quarter

1400

Fair Value

81.08

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

47.5

Max Drawdown 5-Year %

-66.3

Target Price

95.12

P/E

34.19

Forward P/E

27.76

PEG

1.31

P/S

6.58

P/B

12.47

P/Free Cash Flow

23.26

EPS

2.53

Average EPS Est. Cur. Y

2.66

EPS Next Y. (Est.)

3.12

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

20.12

Relative Volume

0.4

Return on Equity vs Sector %

11.9

Return on Equity vs Industry %

26.6

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

-97.1

◆ DXCM Healthcare

$86.62

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

2/20

Pullback

13/25

Volume

11/15

Valuation

9/20

TP/AR

5/10

Options

4/10

RSI

48.7

Range 1M

46.9%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

6/25

Growth

23/30

Estimates

11/20

Inst/Vol

7/15

Options

5/10

EPS Yr

27.6%

EPS NY

17%

52W%

85.5%

💎

Long-Term Value

Quality companies, undervalued

WATCH

🟡 HOLD +13.1% upside

Quality

30/30

Valuation

8/30

Growth

19/25

Stability

6/10

LT Trend

0/5

Upside

+13.1%

Quality

MoS

-6%

DXCM — P/E HistoricalDiagnostics & Research

DexCom, Inc.

Sector: Healthcare

Industry: Medical Devices

Employees: 11000

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

DXCM

Latest News

—

Caricamento notizie per DXCM…

stock quote shares DXCM – DexCom, Inc. Stock Price stock today

news today DXCM – DexCom, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch DXCM – DexCom, Inc. yahoo finance google finance

stock history DXCM – DexCom, Inc. invest stock market

stock prices DXCM premarket after hours

ticker DXCM fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: DXCM

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y